Project Description
Enabling homes to realise zero pollution holds multiple health benefits for all Europeans – especially our children. This is the goal of the EU-funded INQUIRE project. It will provide the knowledge, tools and measures needed to significantly enhance indoor air quality. Research on hazardous determinants and their sources, risk factors and effects will focus in particular on infants and young children up to 5 years old. The work will include non-invasive sampling and monitoring of over 200 homes in eight countries over the course of 1 month. Results will inform evidence-based recommendations and support beneficial exploitation by industry and policymakers.
News & Events
NEW!
Third in-person meeting
This week on 9-10 Sept. 2024, the third in-person INQUIRE consortium meeting will be taking place with project partners in Cambridge, UK
September 9, 2024
NEW!
Partner Profile #14
Estonian Research Team: University of Tartu (UT) and Republic of Estonia Health Board (HB)
June 28, 2024
Social media
👉Join below for the next @SynAir_G workshop on #IAQ for healthier children ‼️
📢 Don't forget to #subscribe to the @KHEALTHinAIR_EU newsletter to learn more about how #IndoorAirQuality affects human #health ‼️
#IAQ @INQUIRE_EU @IDEAL_CLUSTER
📢Check it out‼️
The #EuropeanCommission has highlighted the
@IDEAL_CLUSTER, and its associated projects, as one of the most relevant research initiatives in the field of #IndoorAirQuality 🥳
@INQUIRE_EU #IAQ
Participants & Partners
NILU, Norway
UA, Belgium
UCAM, UK
UMU, Sweden
INEGI, Portugal
KI, Sweden
ISS, Italy
Health Board Terviseamet, Estonia
UH, Finland
SU, Sweden
JSI, Slovenia
UTARTU, Estonia
KU, Sweden
VUA, Netherlands
UOB, UK
VITO, Belgium
MU, Czech Republic
UQ, Australia
QUT, Australia
Mann+Hummel, Germany
Funding
This work was co-funded by UK Research and Innovation (UKRI) under the UK government’s Horizon Europe funding guarantee [grant number 10038689 and 10042425].
Co-funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Health and Digital Executive Agency (HaDEA). Neither the European Union nor the granting authority can be held responsible for them.
The work received funding support from the Australian National Health and Medical Research Council (NHMRC) [NHMRC; 2022/GNT2017837].